Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome

US Patent 9265754 · Granted Feb 23, 2016

Estimated economic value: $11,195,000

Assignee

Inventors

View full patent text on Google Patents →